Funds

3

Vintages

2017 to 2022

Reported GAV

$581Mgross asset value on Form ADV; never dry powder

Funds with fundraising evidence

0derived

Investments

2

Portfolio companies

2

Investments, 12m

2

Partner-attributed

0

People

6

Investment professionals

1derived

Co-investors

0derived

LP relationships

0

Stated sectors

healthcare,biotechas stated by the firm

Stated geography

boston,europe,global,north america,united states

Latest Form D

Oct 28, 2025

Latest ADV filing

Jun 25, 2026

Website

pivotalbiovp.com

• Occurred

  Aug 1, 2022
  Person joined

  Michael Lawrence Travers joined Schedule A of Pivotal Bioventure Partners as Corporate Counsel And Chief Operating Officer

  Form ADVobserved 7 days ago
• Occurred

  Jun 28, 2022
  Person left

  Heather Preston (Officer) no longer on Schedule A of Pivotal Bioventure Partners

  Form ADVobserved 7 days ago
• Occurred

  Jun 1, 2022
  Person joined

  Peter Tuxen Bisgaard joined Schedule A of Pivotal Bioventure Partners as Managing Director

  Form ADVobserved 7 days ago
• Occurred

  Jul 1, 2018
  Person joined

  Heather Preston joined Schedule A of Pivotal Bioventure Partners as Officer

  Form ADVobserved 7 days ago
• Occurred

  Jun 29, 2018
  Person left

  Tracy M Saxton (Officer) no longer on Schedule A of Pivotal Bioventure Partners

  Form ADVobserved 7 days ago
• Occurred

  Mar 1, 2018
  Person joined

  Brian Kin Kwok Tse joined Schedule A of Pivotal Bioventure Partners as Officer

  Form ADVobserved 7 days ago
• Occurred

  Dec 1, 2017
  Person joined

  Robert Lorne Hopfner joined Schedule A of Pivotal Bioventure Partners as Officer

  Form ADVobserved 7 days ago
• Occurred

  Mar 16, 2017
  Adviser's first ADV filing

  Pivotal Bioventure Partners first filed Form ADV (ERA, venture capital fund adviser exemption)

  Form ADVobserved 7 days ago

Also named here, with no published line of their own (reach them through the firm): Pivotal Public Equity (Portfolio), United States (Investment), Michael Lawrence Travers (Corporate Counsel And Chief Operating Officer), Brian Kin Kwok Tse (Officer), Robert Lorne Hopfner (Officer), Peter Tuxen Bisgaard (Managing Director).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:1a2cc31c-7442-4a49-9fb4-8cf6d1db61c1

First observed

Sep 12, 2026

Last observed

Sep 17, 2026 2 days ago

Source families

Federal regulator filings, Firm and issuer disclosures

3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.